Global Clinical Decision Support System (CDSS) Market Research Report: Forecast (2024-2030)

Market Definition

A clinical decision support system (CDSS) is a healthcare technology that encompasses a variety of tools and interventions that give patient-specific information to healthcare service providers allowing them to make informed decisions thereby improving patient care.

 Market Insights & Analysis: Global Clinical Decision Support System (CDSS) Market (2024-30):  

The Global Clinical Decision Support System (CDSS) Market size was valued at USD 5.30 billion in 2023 and is projected to reach USD 10.71 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 10.79% during the forecast period, i.e., 2024-30. Globally, the occurrence of various chronic diseases including CVD & cancer has been growing at an alarming rate. This necessitates healthcare professionals to accurately & precisely diagnose & monitor the progression of health conditions to advance patient outcomes.

*Boost strategic growth with in-depth market analysis - Get a free sample preview today!

Clinical decision support systems (CDSS) offer healthcare providers medical data comprising essential information such as patient history, test results, and research findings on comparable cases, aiding them in the diagnosis process. Also, with AI applications, CDSS helps medical professionals to be more prompt & precise and make informed decisions about disease diagnosis, resulting in higher adoption of clinical decision support systems (CDSS) in healthcare facilities leading to the improvement in quality of care & enhanced patient outcomes. For instance,

• The World Health Organisation (WHO) reported in 2022 about 20 million new cases of cancer globally and also expects that the cases would increase to 32.6 million by 2045.

Furthermore, factors such as lack or inadequate information flow, poor documentation of information, insufficiencies in training & education, and others along with several types of medical errors including surgical, diagnostic, medication, etc. have been increasingly reported across various healthcare facilities globally. The occurrence of medical errors is attributed to poor health outcomes of patients resulting in increased mortality. Due to this, it has become a necessity for medical facilities to incorporate a clinical decision support system (CDSS) that highlights errors and thus enhances error prevention. Subsequently, the Global Market for Clinical Decision Support Systems (CDSS) has been experiencing positive growth trends. For instance,

• As stated by WHO in 2023, globally, 1 in every 10 patients is harmed in healthcare with diagnostic errors, medication errors, surgical errors, etc. being the potential sources of harm. Also, on an annual basis, around 3 million deaths occur due to unsafe care or medical errors.

Additionally, rising healthcare costs across countries like the US, Canada, China, India, Middle East, Europe and others, have pressed the need for the adoption of clinical decision support systems (CDSS) for the reduction of increasing healthcare costs. These systems highlight the repetition of suggested diagnostic tests, provide apt diagnosis, reduce medical errors, provide evidence-based therapeutic recommendations, and allow for enhanced patient outcomes by reducing hospital stay time and ultimately the overall costs. Ultimately, the Clinical Decision Support System Market has been expanding globally.

Global Clinical Decision Support System (CDSS) Market Driver:

Government Initiatives for the Adoption of Digital Healthcare Technologies to Impact Market Positively –  The governments of many countries including the US, UK, Germany, India, Australia, and others have realized benefits such as enhanced patient outcomes, reduced medical errors & healthcare costs, etc., of clinical decision support systems (CDSS). Subsequently, the government authorities have been taking valuable steps including the implementation of policies as well as providing necessary funding or investment to support the integration of such advanced technologies and systems in healthcare facilities. As a result, the demand for clinical decision support systems (CDSS) has witnessed a remarkable boost, positively impacting the market growth.  

Moreover, government support has not only encouraged healthcare providers to adopt the Clinical Decision Support System (CDSS) but has also stimulated innovation and competition among key players like Philips, Wolters Kluwer N.V., Epic Systems, IBM, and others. The government bodies too have been offering adequate support & funding to companies keen on developing clinical decision tools. Consequently, the market for Clinical Decision Support Systems (CDSS) has been expanding in market size. For instance,

• In 2022, the Tommy's App, an in-development clinical decision support tool for maternity care was awarded funding of USD2.34 million by the UK’s National Health Service (NHS).

Global Clinical Decision Support System (CDSS) Market Challenge:

Data Security & Privacy Concerns with Clinical Decision Support System (CDSS) to Impact Market Negatively – Although the revolutionary applications of clinical decision support systems (CDSS) in diagnosis & patient management have made them popular among healthcare providers, still there are certain limitations such as those related to data privacy & security which tend to limit their complete adoption. The issues including concerns about increasing cyber-attacks in the healthcare sector, unauthorized access to third parties due to growing digitalization, etc. have raised the alarms in the minds of certain healthcare providers & largely the patients. Due to this adoption & acceptance of clinical decision support systems (CDSS) have been limited. Moreover, the shortage of skilled IT healthcare professionals to handle such consequences has further restricted the adoption of CDSS. This resulted in negatively impacting the overall market for Clinical Decision Support Systems (CDSS).

Global Clinical Decision Support System (CDSS) Market Trend:

Integration with Electronic Health Records (EHR) – With the increase in the aging population aging & changing patient expectations, there has been a rise in demand for improved healthcare outcomes. This leads to the development of a highly improved, efficient, and effective health system integrated with electronic health records (EHR) and the clinical decision support system. CDSS systems integrated with EHR provide real-time access to patient data to healthcare professionals including his/her medical history, medication records, etc. thus improving the efficiency & accuracy of clinical decision-making.

For instance, Companies like EvidenceCare, Change Healthcare, etc. have been offering innovative EHR-integrated clinical decision support software that gives doctor’s right information at the right time without the need to perform invasive tests.

Further, as the focus is growing on making genetic information part of electronic health records (EHR), the inclination towards precision medicine that is exclusively based on leveraging patients’ genetic information would enhance the adoption of CDSS systems integrated with EHR. Hence, considering the aforementioned factors the market for Global Clinical Decision Support System (CDSS) would be experiencing positive growth trends in the coming years as well.

Global Clinical Decision Support System (CDSS) Market (2024-30): Segmentation Analysis

The Global Clinical Decision Support System (CDSS) Market study of MarkNtel Advisors evaluates & highlights the major trends & influencing factors in each segment & includes predictions for the period 2024–2030 at the global levels. Based on the analysis, the market has been further classified as:

Based on Application:

• Diagnosis Support
• Treatment Planning & Drug Management
• Patient Monitoring & Management
• Others

Out of these, the treatment planning & drug management category held a considerable market share of the Global Clinical Decision Support System Market. The market growth owes to an increased number of cases of adverse drug reactions (ADR) that have been reported globally across healthcare facilities which necessitated the utilization of a clinical decision support system (CDSS) for treatment planning & drug management. This is to have an idea about patients’ medical history and possible drug interactions that could be avoided for better patient outcomes.

Further, many patients have a drug allergy which if not known beforehand could have significant negative impacts on the overall condition of the patient. As a result, demand for CDSS for treatment planning & drug management has increased in many healthcare facilities in countries like the US, UK, Germany, etc. to have access to patient’s drug allergy profiles. Subsequently, the category’s market experiences considerable growth. Moreover, the fact that not every drug treats patients with diseases like cancer & HIV effectively and lessens their chances of survival, has led to the increased adoption of CDSS by medical professionals. This is because CDDS allows them to prescribe patients with such deadly diseases, the most suitable medication based on medical history & present medication regimen. Hence, the market size of treatment planning & drug management has been expanding globally.

Based on End-User:

• Hospitals & Clinics
• Ambulatory Surgical Centers
• Others

Out of them, the hospitals & clinics category held the prominent market share of the Global Clinical Decision Support System (CDSS) Market. This has been because the major healthcare facilities, hospitals & clinics have been visited by patients in large numbers, thereby generating vast amounts of patient data. As a result, it has become essential for facilities to adopt CDSS to enhance the clinical documentation process, store large volumes of data, and avoid medical errors. Consequently, the hospitals & clinics category registers significant growth.

Further, in recent years, to cater to the growing patient population, boost medical tourism, generate profits, etc. private healthcare institutions have been investing in the construction of newer hospitals & clinics which tend to generate an opportunistic demand for CDSS. Moreover, governments have been taking steps including providing necessary funding and investments to boost the healthcare infrastructure of their countries and support the adoption of advanced healthcare technologies like CDSS. Due to this as well, the overall market for the hospital & clinics category has been experiencing remarkable growth.

Global Clinical Decision Support System (CDSS) Market (2024-30): Regional Projection

Geographically, the Global Clinical Decision Support System (CDSS) Market expands across:

• North America
• South America
• Europe
• The Middle East & Africa
• Asia-Pacific

North America would hold a significant market share in the Global Clinical Decision Support System (CDSS) Market. The region’s large elderly population has elevated the rates of many diseases including CVDs, cancer, bone diseases, kidney disorders, etc. Due to this, visitations to the region’s healthcare facilities have increased tremendously thereby contributing to the production of a large volume of healthcare data. Subsequently, a need for a Clinical Decision Support System (CDSS) to manage data effectively without causing costly mistakes, has increased in the region.

Further, in the North American region, the mortality rates due to medical errors caused because of poor judgment or care, a system defect, mix-ups, etc. have been high. This successfully boosted the adoption of the Clinical Decision Support System (CDSS) to reduce mortality rates & improve patient outcomes with the removal of medical errors.

Moreover, healthcare facilities in countries like the US & Canada with government investments have been actively adopting the Clinical Decision Support System (CDSS) to stay up-to-date with continuously evolving healthcare guidelines and offer patients with best possible treatment. Hence collectively the above-mentioned factors have been accelerating the market growth of Clinical Decision Support Systems (CDSS) in the North American region.

Global Clinical Decision Support System (CDSS) Recent Development:

• 2024: Elsevier Health announced the launch of ClinicalKey AI, an advanced Gen AI-powered clinical decision support tool for clinicians.
• 2024: Zynx Health launched a comprehensive, customizable, clinical decision support solution named Zynx for Primary Care tailored for primary care settings.

Gain a Competitive Edge with Our Global Clinical Decision Support System (CDSS) Market Report

• Global Clinical Decision Support System (CDSS) Market Report by MarkNtel Advisors provides a detailed & thorough analysis of market size & share, growth rate, competitive landscape, and key players. This comprehensive analysis helps businesses gain a holistic understanding of the market dynamics & make informed decisions.
• This report also highlights current market trends & future projections, allowing businesses to identify emerging opportunities & potential challenges. By understanding market forecasts, companies can align their strategies & stay ahead of the competition.
• Global Clinical Decision Support System (CDSS) Market Report aids in assessing & mitigating risks associated with entering or operating in the market. By understanding market dynamics, regulatory frameworks, and potential challenges, businesses can develop strategies to minimize risks & optimize their operations.

*Reports Delivery Format  - Market research studies from MarkNtel Advisors are offered in PDF, Excel and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address.